Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Medical Specialties (7)
- Pediatrics (5)
- Diseases (3)
- Medical Sciences (3)
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)
-
- Mental and Social Health (2)
- Patient Safety (2)
- Pharmacy and Pharmaceutical Sciences (2)
- Psychiatric and Mental Health (2)
- Public Health (2)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (1)
- Diagnosis (1)
- Emergency Medicine (1)
- Health Services Research (1)
- Hematology (1)
- Hemic and Lymphatic Diseases (1)
- Hormones, Hormone Substitutes, and Hormone Antagonists (1)
- Immune System Diseases (1)
- Infectious Disease (1)
- Interprofessional Education (1)
- Medical Biochemistry (1)
- Medical Education (1)
- Medical Toxicology (1)
- Nephrology (1)
- Nursing (1)
- Other Chemicals and Drugs (1)
- Otolaryngology (1)
- Institution
Articles 1 - 8 of 8
Full-Text Articles in Pharmaceutical Preparations
Oxcarbazepine Overdose In A Polysubstance Related Suicide, Melissa Beals, Robert J. Krumsick, C. Clinton Frazee Iii, Lindsey J. Haldiman, Uttam Garg
Oxcarbazepine Overdose In A Polysubstance Related Suicide, Melissa Beals, Robert J. Krumsick, C. Clinton Frazee Iii, Lindsey J. Haldiman, Uttam Garg
Posters
Introduction
Oxcarbazepine is a derivative of carbamazepine that is used primarily in the treatment of epilepsy, and experimentally as a mood-stabilizer in adjunctive therapy for the treatment of bipolar disorder. Oxcarbazepine is converted through oxidation to its pharmacologically active metabolite 10-OH-Carbazepine, which is thought to be responsible for most of the anticonvulsant action of the drug. Adverse effects of oxcarbazepine are generally dose-dependent and may include fatigue, somnolence, dizziness, diplopia, nystagmus, and ataxia. Additive sedative effects have been noted when oxcarbazepine is used in combination with other CNS depressionproducing medications. Furthermore, oxcarbazepine and 10-OH-Carbazepine are powerful CYP2C19 inhibitors, potentially increasing …
Sustainability And Outcomes Of A Standardized Aminoglycoside Induced Ototoxicity Monitoring Algorithm, Claire Elson, Christopher M. Oermann, Michelle Weltman, Ellen Meier
Sustainability And Outcomes Of A Standardized Aminoglycoside Induced Ototoxicity Monitoring Algorithm, Claire Elson, Christopher M. Oermann, Michelle Weltman, Ellen Meier
Posters
No abstract provided.
Cannabinoid Therapy In Chronic Pain Management, Breanna Joy Privratsky
Cannabinoid Therapy In Chronic Pain Management, Breanna Joy Privratsky
Physician Assistant Scholarly Project Posters
In 1996, the state of California was the first in the union to allow for the use of medical marijuana. Since then, 28 more states have enacted similar laws (National Conference of State Legislatures, [NCSL], 2017). With the ever-growing opiate problem that has now been classified as an epidemic by the Centers for Disease Control and Prevention, medical marijuana could be a viable alternative to this problem.
As of 2014, the CDC reported opioid deaths were up 369%, which is more than 91 deaths per day from overdose (Centers for Disease Control, [CDC], 2017). The purpose of this study is …
A Ninja Initiative At Children's Mercy, Richard Ogden, Bradley A. Warady, Vimal Chadha, Wendy Hoebing
A Ninja Initiative At Children's Mercy, Richard Ogden, Bradley A. Warady, Vimal Chadha, Wendy Hoebing
Posters
No abstract provided.
The Association Of Hormonal Contraception With Depression, Pamela Derickson
The Association Of Hormonal Contraception With Depression, Pamela Derickson
Family Medicine Clerkship Student Projects
Hormonal contraceptives are widely used by women during their reproductive years. Currently, over 100 million women worldwide use the pill, and 82% of sexually active women in the USA will use oral contraceptive pills at some time during their reproductive years (Carrol, 2017). Oral contraceptive use, especially among adolescents, is associated with subsequent use of antidepressants and a first diagnosis of depression, suggesting depression may be a potential adverse effect of hormonal contraceptive use (Skovlund, 2016). This project focused on educating health care providers at the Community Health Center of Burlington, VT (CHCB) about the association of depression and oral …
Pharmacy Driven Best Possible Admission Medication History At A Pediatric Institution, Damon Pabst, Charity Thompson, Brandon French, Brian O'Neal, Garret Matthews, Zeb Benner, Joshua Meade
Pharmacy Driven Best Possible Admission Medication History At A Pediatric Institution, Damon Pabst, Charity Thompson, Brandon French, Brian O'Neal, Garret Matthews, Zeb Benner, Joshua Meade
Posters
No abstract provided.
Medication Education In The Pediatric Rheumatology Clinic, Ashley M. Cooper, Julia G. Harris
Medication Education In The Pediatric Rheumatology Clinic, Ashley M. Cooper, Julia G. Harris
Posters
No abstract provided.
Medication Timeliness In Emergency Department In Pediatric Sickle Cell Disease Population Presenting With Vaso-Occlusive Episode, Derrick Goubeaux, Kaitlyn Hoch, Gerald Woods, Julie Routhieaux, Maureen Guignon, Valerie Mcdougall Kestner
Medication Timeliness In Emergency Department In Pediatric Sickle Cell Disease Population Presenting With Vaso-Occlusive Episode, Derrick Goubeaux, Kaitlyn Hoch, Gerald Woods, Julie Routhieaux, Maureen Guignon, Valerie Mcdougall Kestner
Posters
No abstract provided.